+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Carbetocin Market - Global Forecast 2026-2032- Product Image
Carbetocin Market - Global Forecast 2026-2032- Product Image
New

Carbetocin Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 182 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6010691
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The carbetocin market is experiencing strong momentum as evolving clinical needs, supply constraints, and regulatory shifts redefine how uterotonic therapies are positioned and procured across global maternal health systems. This landscape demands actionable intelligence for decision-makers seeking both operational efficiency and elevated standards of care.

Market Snapshot: Growth, Demand, and Shifting Dynamics

The carbetocin market grew from USD 224.63 million in 2025 to USD 240.24 million in 2026. It is projected to continue expanding at a CAGR of 6.92%, ultimately reaching USD 359.05 million by 2032. Sustained market growth is driven by increasing adoption of reliable uterotonic agents, expanded utility of heat-stable formulations, and greater demand for resilient supply solutions. Shifts in global healthcare infrastructure, wider recognition of postpartum hemorrhage prevention, and innovations in pharmaceutical manufacturing further underpin steady uptake across multi-regional channels.

Scope & Segmentation

This analysis delivers granular insights and actionable segmentation relevant to market participants, highlighting areas of clinical, operational, and commercial importance:

  • Clinical Indications: Prevention and treatment of postpartum hemorrhage during cesarean and vaginal deliveries
  • Formulation Types: Heat-stable and ready-to-use injection formats, prefilled syringes, vials
  • Route of Administration: Intramuscular, intravenous (IM, IV)
  • End-User Settings: Hospitals, birthing centers, clinics, community health facilities
  • Distribution Channels: Hospital pharmacies, retail pharmacy networks, decentralized clinical sites
  • Regional Coverage: Americas, Europe, Middle East & Africa, Asia-Pacific
  • Technologies: Sterile injectable manufacturing, cold-chain and heat-stable packaging, contract development and manufacturing partnerships

Primary Keyword: Carbetocin Market

Key Takeaways for Senior Decision-Makers

  • Heat-stable, ready-to-use formulations drive adoption, especially where cold-chain limitations hinder standard oxytocin use.
  • Single-dose administration simplifies intrapartum workflows and reduces repeat dosing requirements, offering operational efficiency for diverse clinical settings.
  • Shifting procurement priorities emphasize supply chain resilience, favoring strategic supplier diversification and stable manufacturing partnerships.
  • Clinical guidelines are increasingly updated to recognize carbetocin, partly due to its reliability when cold storage is unfeasible, supporting use in both high- and low-resource environments.
  • Stakeholders—from hospitals to policy makers—evaluate its clinical and operational value, integrating evidence on safety, regulatory compliance, and logistics simplicity.
  • Formulation and administration route choice is informed by end-user needs, with birthing centers favoring ease of handling while large institutions prefer formats compatible with existing pharmacy practices.

Tariff Impact: Navigating Regulatory and Trade Shifts

Policy changes in 2025 introduced new complexities to procurement and distribution strategies for injectable therapies. Adjustments to tariff regimes have influenced sourcing models, margin assumptions, and contract terms for carbetocin, necessitating scenario planning and supplier diversification. Health systems have responded by accelerating multi-source tendering and negotiating longer-term supply agreements that incorporate tariff mitigation measures. These forces reinforce the strategic value of heat-stable formats and transparent partnerships within the distribution network.

Methodology & Data Sources

Robust mixed-methods research underpins this report. Secondary research included comprehensive review of clinical literature, regulatory publications, and industry documents to clarify clinical profiles and supply dynamics. Primary research captured direct stakeholder input via structured interviews with obstetricians, pharmacists, procurement executives, and manufacturing specialists. Cross-validation ensured accuracy, triangulating insights across clinical, operational, and commercial perspectives.

Why This Report Matters

  • Enables procurement leaders and clinical directors to confidently align product portfolios with shifting practical and regulatory requirements.
  • Empowers manufacturers and distributors to proactively manage risk by understanding supply chain and tariff-driven challenges unique to sterile injectables.
  • Delivers actionable segmentation and regional perspective to support tailored market access, resource allocation, and strategic planning.

Conclusion

The carbetocin market stands at the intersection of clinical advancement and operational necessity. Strategic product formats and adaptive supply chain approaches will define success for leaders navigating a complex, evolving maternal health landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Carbetocin Market, by Indication
8.1. Prevention Of Postpartum Hemorrhage
8.1.1. Cesarean Section
8.1.2. Vaginal Delivery
8.2. Treatment Of Postpartum Hemorrhage
8.2.1. Cesarean Section
8.2.2. Vaginal Delivery
9. Carbetocin Market, by Formulation
9.1. Prefilled Syringe
9.2. Vial
10. Carbetocin Market, by Route Of Administration
10.1. Intramuscular
10.2. Intravenous
11. Carbetocin Market, by End User
11.1. Birthing Centers
11.2. Clinics
11.3. Hospitals
12. Carbetocin Market, by Distribution Channel
12.1. Hospital Pharmacies
12.2. Retail Pharmacies
13. Carbetocin Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Carbetocin Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Carbetocin Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Carbetocin Market
17. China Carbetocin Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Abbott Laboratories
18.6. Alembic Pharmaceuticals Limited
18.7. Cipla Limited
18.8. Ferring Pharmaceuticals A/S
18.9. Fresenius Kabi AG
18.10. Gland Pharma Limited
18.11. Intas Pharmaceuticals Limited
18.12. Johnson & Johnson Services, Inc.
18.13. Macleods Pharmaceuticals Pvt. Ltd.
18.14. Merck & Co., Inc.
18.15. Novo Nordisk A/S
18.16. Pfizer Inc.
18.17. Sun Pharmaceutical Industries Limited
18.18. Teva Pharmaceutical Industries Ltd.
18.19. Viatris Inc.
List of Figures
FIGURE 1. GLOBAL CARBETOCIN MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL CARBETOCIN MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL CARBETOCIN MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL CARBETOCIN MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL CARBETOCIN MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL CARBETOCIN MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL CARBETOCIN MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CARBETOCIN MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL CARBETOCIN MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES CARBETOCIN MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA CARBETOCIN MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL CARBETOCIN MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL CARBETOCIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL CARBETOCIN MARKET SIZE, BY CESAREAN SECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL CARBETOCIN MARKET SIZE, BY CESAREAN SECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CARBETOCIN MARKET SIZE, BY CESAREAN SECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL CARBETOCIN MARKET SIZE, BY VAGINAL DELIVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL CARBETOCIN MARKET SIZE, BY VAGINAL DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL CARBETOCIN MARKET SIZE, BY VAGINAL DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL CARBETOCIN MARKET SIZE, BY CESAREAN SECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL CARBETOCIN MARKET SIZE, BY CESAREAN SECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL CARBETOCIN MARKET SIZE, BY CESAREAN SECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL CARBETOCIN MARKET SIZE, BY VAGINAL DELIVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL CARBETOCIN MARKET SIZE, BY VAGINAL DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL CARBETOCIN MARKET SIZE, BY VAGINAL DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL CARBETOCIN MARKET SIZE, BY PREFILLED SYRINGE, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL CARBETOCIN MARKET SIZE, BY PREFILLED SYRINGE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL CARBETOCIN MARKET SIZE, BY PREFILLED SYRINGE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL CARBETOCIN MARKET SIZE, BY VIAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL CARBETOCIN MARKET SIZE, BY VIAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL CARBETOCIN MARKET SIZE, BY VIAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL CARBETOCIN MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL CARBETOCIN MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL CARBETOCIN MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL CARBETOCIN MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL CARBETOCIN MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL CARBETOCIN MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL CARBETOCIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL CARBETOCIN MARKET SIZE, BY BIRTHING CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL CARBETOCIN MARKET SIZE, BY BIRTHING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL CARBETOCIN MARKET SIZE, BY BIRTHING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL CARBETOCIN MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL CARBETOCIN MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL CARBETOCIN MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL CARBETOCIN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL CARBETOCIN MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL CARBETOCIN MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL CARBETOCIN MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL CARBETOCIN MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL CARBETOCIN MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL CARBETOCIN MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL CARBETOCIN MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL CARBETOCIN MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL CARBETOCIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. AMERICAS CARBETOCIN MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 56. AMERICAS CARBETOCIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 57. AMERICAS CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2018-2032 (USD MILLION)
TABLE 58. AMERICAS CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2018-2032 (USD MILLION)
TABLE 59. AMERICAS CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 60. AMERICAS CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 61. AMERICAS CARBETOCIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 62. AMERICAS CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 63. NORTH AMERICA CARBETOCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. NORTH AMERICA CARBETOCIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 65. NORTH AMERICA CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2018-2032 (USD MILLION)
TABLE 66. NORTH AMERICA CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2018-2032 (USD MILLION)
TABLE 67. NORTH AMERICA CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 68. NORTH AMERICA CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 69. NORTH AMERICA CARBETOCIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 70. NORTH AMERICA CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 71. LATIN AMERICA CARBETOCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. LATIN AMERICA CARBETOCIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 73. LATIN AMERICA CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2018-2032 (USD MILLION)
TABLE 74. LATIN AMERICA CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2018-2032 (USD MILLION)
TABLE 75. LATIN AMERICA CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 76. LATIN AMERICA CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 77. LATIN AMERICA CARBETOCIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 78. LATIN AMERICA CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA CARBETOCIN MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA CARBETOCIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2018-2032 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2018-2032 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA CARBETOCIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 87. EUROPE CARBETOCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. EUROPE CARBETOCIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 89. EUROPE CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2018-2032 (USD MILLION)
TABLE 90. EUROPE CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2018-2032 (USD MILLION)
TABLE 91. EUROPE CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 92. EUROPE CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 93. EUROPE CARBETOCIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 94. EUROPE CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 95. MIDDLE EAST CARBETOCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. MIDDLE EAST CARBETOCIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 97. MIDDLE EAST CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2018-2032 (USD MILLION)
TABLE 98. MIDDLE EAST CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2018-2032 (USD MILLION)
TABLE 99. MIDDLE EAST CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 100. MIDDLE EAST CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 101. MIDDLE EAST CARBETOCIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 102. MIDDLE EAST CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 103. AFRICA CARBETOCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. AFRICA CARBETOCIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 105. AFRICA CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2018-2032 (USD MILLION)
TABLE 106. AFRICA CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2018-2032 (USD MILLION)
TABLE 107. AFRICA CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 108. AFRICA CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 109. AFRICA CARBETOCIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 110. AFRICA CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 111. ASIA-PACIFIC CARBETOCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. ASIA-PACIFIC CARBETOCIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 113. ASIA-PACIFIC CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2018-2032 (USD MILLION)
TABLE 114. ASIA-PACIFIC CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2018-2032 (USD MILLION)
TABLE 115. ASIA-PACIFIC CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 116. ASIA-PACIFIC CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 117. ASIA-PACIFIC CARBETOCIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 118. ASIA-PACIFIC CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL CARBETOCIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. ASEAN CARBETOCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. ASEAN CARBETOCIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 122. ASEAN CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2018-2032 (USD MILLION)
TABLE 123. ASEAN CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2018-2032 (USD MILLION)
TABLE 124. ASEAN CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 125. ASEAN CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 126. ASEAN CARBETOCIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 127. ASEAN CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 128. GCC CARBETOCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. GCC CARBETOCIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 130. GCC CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2018-2032 (USD MILLION)
TABLE 131. GCC CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2018-2032 (USD MILLION)
TABLE 132. GCC CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 133. GCC CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 134. GCC CARBETOCIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 135. GCC CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 136. EUROPEAN UNION CARBETOCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 137. EUROPEAN UNION CARBETOCIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 138. EUROPEAN UNION CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2018-2032 (USD MILLION)
TABLE 139. EUROPEAN UNION CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2018-2032 (USD MILLION)
TABLE 140. EUROPEAN UNION CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 141. EUROPEAN UNION CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 142. EUROPEAN UNION CARBETOCIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 143. EUROPEAN UNION CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 144. BRICS CARBETOCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 145. BRICS CARBETOCIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 146. BRICS CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2018-2032 (USD MILLION)
TABLE 147. BRICS CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2018-2032 (USD MILLION)
TABLE 148. BRICS CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 149. BRICS CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 150. BRICS CARBETOCIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 151. BRICS CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 152. G7 CARBETOCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. G7 CARBETOCIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 154. G7 CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2018-2032 (USD MILLION)
TABLE 155. G7 CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2018-2032 (USD MILLION)
TABLE 156. G7 CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 157. G7 CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 158. G7 CARBETOCIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 159. G7 CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 160. NATO CARBETOCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 161. NATO CARBETOCIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 162. NATO CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2018-2032 (USD MILLION)
TABLE 163. NATO CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2018-2032 (USD MILLION)
TABLE 164. NATO CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 165. NATO CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 166. NATO CARBETOCIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 167. NATO CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL CARBETOCIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. UNITED STATES CARBETOCIN MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 170. UNITED STATES CARBETOCIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 171. UNITED STATES CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2018-2032 (USD MILLION)
TABLE 172. UNITED STATES CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2018-2032 (USD MILLION)
TABLE 173. UNITED STATES CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 174. UNITED STATES CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 175. UNITED STATES CARBETOCIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 176. UNITED STATES CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 177. CHINA CARBETOCIN MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 178. CHINA CARBETOCIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 179. CHINA CARBETOCIN MARKET SIZE, BY PREVENTION OF POSTPARTUM HEMORRHAGE, 2018-2032 (USD MILLION)
TABLE 180. CHINA CARBETOCIN MARKET SIZE, BY TREATMENT OF POSTPARTUM HEMORRHAGE, 2018-2032 (USD MILLION)
TABLE 181. CHINA CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 182. CHINA CARBETOCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 183. CHINA CARBETOCIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 184. CHINA CARBETOCIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

  • Abbott Laboratories
  • Alembic Pharmaceuticals Limited
  • Cipla Limited
  • Ferring Pharmaceuticals A/S
  • Fresenius Kabi AG
  • Gland Pharma Limited
  • Intas Pharmaceuticals Limited
  • Johnson & Johnson Services, Inc.
  • Macleods Pharmaceuticals Pvt. Ltd.
  • Merck & Co., Inc.
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages182
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 240.24 Million
Forecasted Market Value ( USD ) by 2032 $ 359.05 Million
Compound Annual Growth Rate6.9%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Heat Stable Carbetocin Market - Global Forecast 2026-2032 - Product Image

Heat Stable Carbetocin Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
Carbetocin for Injection Market - Global Forecast 2026-2032 - Product Image

Carbetocin for Injection Market - Global Forecast 2026-2032

  • Report
  • 185 Pages
  • Global
From
Oxytocin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Oxytocin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 180 Pages
  • Global
From
Oxytocin Market - Global Strategic Business Report - Product Image

Oxytocin Market - Global Strategic Business Report

  • Report
  • 276 Pages
  • Global
From
Carboprost Tromethamine - Global Strategic Business Report - Product Image

Carboprost Tromethamine - Global Strategic Business Report

  • Report
  • 276 Pages
  • Global
From

About the Carbetocin Market

Carbetocin is a synthetic oxytocin analogue used in the treatment of postpartum haemorrhage (PPH). It is a drug used in the field of Sexual and Reproductive Health (SRH) and is administered intravenously or intramuscularly. Carbetocin is used to reduce the risk of PPH, a major cause of maternal mortality and morbidity. It is also used to reduce the need for additional uterotonics and to reduce the risk of uterine atony. Carbetocin has been shown to be more effective than oxytocin in preventing PPH and has fewer side effects. Carbetocin is available in many countries, including the United States, Canada, Australia, and the United Kingdom. It is approved for use in the treatment of PPH in the United States and Canada. Some companies in the Carbetocin market include Ferring Pharmaceuticals, Pfizer, Merck, and Novartis. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.